|
Status |
Public on Jul 27, 2022 |
Title |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
36109558 |
|
Submission date |
Nov 21, 2021 |
Last update date |
Sep 27, 2022 |
Contact name |
Masanori Fujimoto |
E-mail(s) |
fujimoto212@gmail.com
|
Organization name |
Chiba University
|
Department |
Graduate School of Medicine
|
Lab |
1. Department of Molecular Diagnosis, 2. Department of Endocrinology, Hematology and Gerontology
|
Street address |
Inohana 1-8-1
|
City |
Chiba-city |
State/province |
Chiba-prefecture |
ZIP/Postal code |
260-8677 |
Country |
Japan |
|
|
Platforms (3) |
GPL18480 |
Illumina HiSeq 1500 (Mus musculus) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (30)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE189282 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [bulkRNA-seq_Hepatocyte] |
GSE189283 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ATAC-Seq] |
GSE189284 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ChIP-Seq] |
GSE189285 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_ILC2] |
GSE189286 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_Hepatocyte] |
|
Relations |
BioProject |
PRJNA782343 |